InvestorsHub Logo
icon url

Bubae

03/31/22 9:35 AM

#42164 RE: YouOnlyLiveOnce #42155

What is the latest acquisition? This story is nearly 2 years old and the debt is primarily from the previous failed treatment center operations. Big payments coming up from now until the end of June just for the immediate debt obligations.

Take $150K off the $550K Labrys note from the eligible debt indicated in the Q3 filing. This is an expensive business model throwing off relatively little cash. I don't see how investors like the class "N" note holders ever get their money back. This doesn't include the $400K convertible preferred shares held by Leonite or the approximately $2.5 million owed to the Leons. Much of the purported 75% of ARIA ownership is tied up in the form of options to secure other notes. Happy trading.


For the quarterly period ended September 30, 2021
https://sec.report/Document/0001721868-21-000835/
Authorized and outstanding
The Company has authorized 10,000,000,000 shares with a par value of $0.01 per share. The company has issued and outstanding 3,111,047,811 and 2,027,085,665 shares of common stock at September 30, 2021 and December 31, 2020, respectively.

Leonite Capital, LLC----On Demand---- $535,866

Auctus Fund, LLC---- On Demand---- $100,000

Labrys Fund, LP ---- November 30th-----$63,200

See note below----- May 7, 2022---- $550,000-

See note below----- June 2, 2022----$230,000

Ed Blasiak----Sept. 14, 2021----$55,000

Series N convertible notes----On demand---- $3,229,000



Ethema Continues to Reduce Debt
March 01, 2022 10:19 ET | Source: Ethema Health Corporation
https://www.globenewswire.com/news-release/2022/03/01/2394545/0/en/Ethema-Continues-to-Reduce-Debt.html

...$100,000.00 on March 31, 2022, $150,000.00 on April 30, 2022 and $136,000.00 on May 31, 2022. As long as these payments are made Labrys has agreed not to make any conversions under the note. A similar amendment was made to the Labrys $230,000.00 note dated June 2, 2021 such that there will be no conversions under the note as long as the note is repaid in two equal payments of $127,650.00 on May 31, 2022 and June 30, 2022. The maturity date of the note was amended to June 30, 2022...

The Company entered into a forbearance agreement with Leonite Capital Inc. (“Leonite”) for their note dated July 12, 2020 which limits certain collection activities for payment defaults until June 28, 2022. The current conversion price being employed on the note is $.001 per share.

The Company has made four payments due on the $95,200.00 Geneva Roth Remark Holdings Inc. note dated September 30, 2021 including the latest payment on February 15, 2022 in the amount of $11,424.00.



December 2020 debt restructuring 8K
https://sec.report/Document/0001721868-20-000600/

Leonite Capital LLC

On July 12, 2020, the company entered into a debt extinguishment agreement with Leonite whereby the following occurred:

...On July 12, 2020, the Company entered into a Senior Secured Convertible Note agreement with Leonite for $440,000 with an original issue discount of $40,000 for gross proceeds of $400,000, the initial tranche advanced will be for cash of $200,000 plus the OID of $20,000, the remaining advances will be at the discretion of the Leonite...

...or after a six month period from the effective date at 60% of the lowest trading price during the preceding 21 consecutive trading days...